Neeraj Bhargava
Asia, Maharashtra, India, Mumbai'%3e%3ccircle r='20' fill='%23008'/%3e%3ccircle r='17.5' fill='%23fff'/%3e%3ccircle r='3.5' fill='%23008'/%3e%3cg id='d'%3e%3cg id='c'%3e%3cg id='b'%3e%3cg id='a' fill='%23008'%3e%3ccircle r='.875' transform='rotate(7.5 -8.75 133.5)'/%3e%3cpath d='M0 17.5.6 7 0 2l-.6 5L0 17.5z'/%3e%3c/g%3e%3cuse xlink:href='%23a' transform='rotate(15)'/%3e%3c/g%3e%3cuse xlink:href='%23b' transform='rotate(30)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='rotate(60)'/%3e%3c/g%3e%3cuse xlink:href='%23d' transform='rotate(120)'/%3e%3cuse xlink:href='%23d' transform='rotate(-120)'/%3e%3c/g%3e%3c/svg%3e)
Description
Neeraj Bhargava is the Founder, Chairman, and Group CEO of Rainshine Global Inc. He previously worked at Allygrow as a Director. Neeraj Bhar...
Investor Profile
Neeraj Bhargava has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Convertible Note, Series A rounds (top funding stages).
- Majority of deals are located in India, United States, Singapore.
- Strong thematic focus on Clinical Trials, Health Care, Medical.
Stage Focus
- Seed (33%)
- Convertible Note (33%)
- Series A (33%)
Country Focus
- India (33%)
- United States (33%)
- Singapore (33%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Clinical Trials
- Health Care
- Medical
- Mental Health
- Digital Entertainment
- Sports
- Subscription Service
- Comics
- Film
- Mobile
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
